Results 111 to 120 of about 5,109 (163)
Protein-encapsulated fluorogenic probes for the selective detection of endogenous O-GlcNAcase (OGA). [PDF]
Chem SciWu YH +6 more
europepmc +1 more source
Ligand-human serum albumin analysis: the near-UV CD and UV-Vis spectroscopic studies. [PDF]
Naunyn Schmiedebergs Arch PharmacolRogóż W +3 more
europepmc +1 more source
Rapid Characterization of Undeclared Pharmaceuticals in Herbal Preparations by Ambient Ionization Mass Spectrometry for Emergency Care. [PDF]
J Am Soc Mass SpectromLee CW +7 more
europepmc +1 more source
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1977 openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Rheumatology, 1975
During a comparative trial between enteric-coated and rectally administered phenylbutazone in patients with rheumatoid disease, one patient developed a mild hepatitis. She had recently concluded a long period of gold therapy. The natural history of phenylbutazone hepatitis is reviewed on the basis of 41 case histories, and the experience with this ...
P D, Fowler, D, Woolf, S, Alexander
openaire +2 more sources
During a comparative trial between enteric-coated and rectally administered phenylbutazone in patients with rheumatoid disease, one patient developed a mild hepatitis. She had recently concluded a long period of gold therapy. The natural history of phenylbutazone hepatitis is reviewed on the basis of 41 case histories, and the experience with this ...
P D, Fowler, D, Woolf, S, Alexander
openaire +2 more sources
Pediatrics, 1956
Phenylbutazone (Butazolidin®), introduced into clinical usage in 1952 as an antirheumatic agent in gout, rheumatoid arthritis and other periarticular diseases, has gained widespread usage among adults, and a report of its accidental ingestion by a 2-year-old infant may therefore be of interest.
openaire +2 more sources
Phenylbutazone (Butazolidin®), introduced into clinical usage in 1952 as an antirheumatic agent in gout, rheumatoid arthritis and other periarticular diseases, has gained widespread usage among adults, and a report of its accidental ingestion by a 2-year-old infant may therefore be of interest.
openaire +2 more sources